Apolo Discusses Promising Immunotherapy Combos in Bladder Cancer – Targeted Oncology
Targeted Oncology |
Apolo Discusses Promising Immunotherapy Combos in Bladder Cancer
Targeted Oncology Apolo, a medical oncologist at the National Cancer Institute and chief of the bladder cancer section of the Genitourinary Malignancies Branch, expressed her excitement about immunotherapy combinations in bladder cancer in an interview with Targeted … |
